Neurotoxicology of Synthetic Cathinone Analogs.
暂无分享,去创建一个
[1] J. Ramsey,et al. High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: Neural consequences and comparison with methamphetamine , 2013, Journal of psychopharmacology.
[2] J. Cadet,et al. Neurotoxicity of substituted amphetamines: Molecular and cellular mechanisms , 2007, Neurotoxicity Research.
[3] M. Kane,et al. Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus. , 2014, Life sciences.
[4] R. Rockhold,et al. Methcathinone intoxication in the rat: abrogation by dextrorphan. , 1997, Annals of emergency medicine.
[5] R. Glennon,et al. "Deconstruction" of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter. , 2013, ACS chemical neuroscience.
[6] B. Yamamoto,et al. Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists. , 1994, European journal of pharmacology.
[7] A. Riley,et al. 3,4-Methylenedioxypyrovalerone (MDPV)-induced conditioned taste avoidance in the F344/N and LEW rat strains , 2014, Pharmacology Biochemistry and Behavior.
[8] J. Cadet,et al. Invited Review Free radicals and the pathobiology of brain dopamine systems , 1998, Neurochemistry International.
[9] A. Ruoho,et al. Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines , 1999 .
[10] W. Slikker,et al. Methamphetamine‐Induced Dopaminergic Neurotoxicity: Role of Peroxynitrite and Neuroprotective Role of Antioxidants and Peroxynitrite Decomposition Catalysts , 2001, Annals of the New York Academy of Sciences.
[11] D. Wong,et al. Reduced Striatal Dopamine Transporter Density in Abstinent Methamphetamine and Methcathinone Users: Evidence from Positron Emission Tomography Studies with [11C]WIN-35,428 , 1998, The Journal of Neuroscience.
[12] A. Csillag,et al. Apoptotic effects of the 'designer drug' methylenedioxypyrovalerone (MDPV) on the neonatal mouse brain. , 2014, Neurotoxicology.
[13] R. Glennon,et al. Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology. , 2014, Life sciences.
[14] H. Sitte,et al. Amphetamines, new psychoactive drugs and the monoamine transporter cycle , 2014, Trends in pharmacological sciences.
[15] T. Robinson,et al. Amphetamine‐Induced time‐dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: A microdialysis study in behaving rats , 1995, Synapse.
[16] K. T. Wakabayashi,et al. Effects of Social Interaction and Warm Ambient Temperature on Brain Hyperthermia Induced by the Designer Drugs Methylone and MDPV , 2015, Neuropsychopharmacology.
[17] M. Reith,et al. Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter. , 2015, Drug and alcohol dependence.
[18] O. Hornykiewicz,et al. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. , 1995, Molecular pharmacology.
[19] F. Ebling,et al. Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat , 2013, European Neuropsychopharmacology.
[20] E. Kiyatkin,et al. Acute methamphetamine intoxication: brain hyperthermia, blood-brain barrier, brain edema, and morphological cell abnormalities. , 2009, International review of neurobiology.
[21] J. Camarasa,et al. Dose and Time-Dependent Selective Neurotoxicity Induced by Mephedrone in Mice , 2014, PloS one.
[22] A. Winstock,et al. Mephedrone in Adolescent Rats: Residual Memory Impairment and Acute but Not Lasting 5-HT Depletion , 2012, PloS one.
[23] D. Kuhn,et al. 3,4‐Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine‐induced damage to dopamine nerve endings: β‐ketoamphetamine modulation of neurotoxicity by the dopamine transporter , 2015, Journal of neurochemistry.
[24] H. Haughey,et al. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia. , 2000, The Journal of pharmacology and experimental therapeutics.
[25] J. Benjamins,et al. Methamphetamine Neurotoxicity in Dopamine Nerve Endings of the Striatum Is Associated with Microglial Activation , 2004, Journal of Pharmacology and Experimental Therapeutics.
[26] M. Gygi,et al. Role of endogenous dopamine in the neurochemical deficits induced by methcathinone. , 1997, The Journal of pharmacology and experimental therapeutics.
[27] Jorge Camarasa,et al. An integrated pharmacokinetic and pharmacodynamic study of a new drug of abuse, methylone, a synthetic cathinone sold as “bath salts” , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[28] T. Watanabe,et al. Sympatho-adrenal involvement in methamphetamine-induced hyperthermia through skeletal muscle hypermetabolism. , 1998, European journal of pharmacology.
[29] M. Liechti,et al. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones , 2015, European Neuropsychopharmacology.
[30] K. Houseknecht,et al. Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone). , 2013, Drug and alcohol dependence.
[31] I. Sora,et al. Methylone and Monoamine Transporters: Correlation with Toxicity , 2011, Current neuropharmacology.
[32] M. Liechti,et al. Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence , 2013, BMC Research Notes.
[33] O. Hornykiewicz,et al. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter. , 2015, European journal of pharmacology.
[34] B. Roth,et al. In Vitro Characterization of Ephedrine-Related Stereoisomers at Biogenic Amine Transporters and the Receptorome Reveals Selective Actions as Norepinephrine Transporter Substrates , 2003, Journal of Pharmacology and Experimental Therapeutics.
[35] R. Dafters. Hyperthermia following MDMA administration in rats: Effects of ambient temperature, water consumption, and chronic dosing , 1995, Physiology & Behavior.
[36] T. Rodrigo,et al. Neuronal changes and oxidative stress in adolescent rats after repeated exposure to mephedrone. , 2015, Toxicology and applied pharmacology.
[37] J. Cadet,et al. Speed kills : cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis , 2003 .
[38] M. Colado,et al. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X7 receptors. , 2014, The international journal of neuropsychopharmacology.
[39] M. Liechti,et al. Pharmacological characterization of designer cathinones in vitro , 2013, British journal of pharmacology.
[40] R. Glennon,et al. Methcathinone: A new and potent amphetamine-like agent , 1987, Pharmacology Biochemistry and Behavior.
[41] G. C. Wagner,et al. Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. , 2003, Journal of pharmacological sciences.
[42] J. Camarasa,et al. Repeated doses of methylone, a new drug of abuse, induce changes in serotonin and dopamine systems in the mouse , 2014, Psychopharmacology.
[43] S. Rawls,et al. Behavioral pharmacology of designer cathinones: a review of the preclinical literature. , 2014, Life sciences.
[44] D. Murphy,et al. Methylone-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. , 2015, Behavioural pharmacology.
[45] J. Camarasa,et al. Interaction of mephedrone with dopamine and serotonin targets in rats , 2012, European Neuropsychopharmacology.
[46] L. Parsons,et al. Effect of Ambient Temperature on the Thermoregulatory and Locomotor Stimulant Effects of 4-Methylmethcathinone in Wistar and Sprague-Dawley Rats , 2012, PloS one.
[47] D. Murphy,et al. Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. , 2007, European journal of pharmacology.
[48] Stuart A. Collins,et al. Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine. , 2014, Life sciences.
[49] C. Ciudad,et al. Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; postulation of unique roles of D3 receptors and BDNF in place preference acquisition , 2015, British journal of pharmacology.
[50] A. Stepens,et al. The outcome of the movement disorder in methcathinone abusers: clinical, MRI and manganesemia changes, and neuropathology , 2014, European journal of neurology.
[51] S. Rozov,et al. Long-term cognitive and neurochemical effects of “bath salt” designer drugs methylone and mephedrone , 2013, Pharmacology Biochemistry and Behavior.
[52] J. Kehr,et al. Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5‐HT levels in nucleus accumbens of awake rats , 2011, British journal of pharmacology.
[53] R. Rothman,et al. The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue , 2012, Neuropsychopharmacology.
[54] O. Levin. ["Ephedron" encephalopathy]. , 2005, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.
[55] A. Boguszewska-Czubara,et al. Mephedrone and Nicotine: Oxidative Stress and Behavioral Interactions in Animal Models , 2015, Neurochemical Research.
[56] R. Glennon,et al. Quantitative structure–activity relationship analysis of the pharmacology of para‐substituted methcathinone analogues , 2015, British journal of pharmacology.
[57] D. Kuhn,et al. Mephedrone, an abused psychoactive component of ‘bath salts’ and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum , 2012, Journal of neurochemistry.
[58] J. Camarasa,et al. Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone , 2012, British journal of pharmacology.
[59] A. Ruoho,et al. Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines. , 1999, European journal of pharmacology.
[60] M. Levine,et al. Acute Methylenedioxypyrovalerone Toxicity , 2014, Journal of Medical Toxicology.
[61] Kurt R. Lehner,et al. Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive ‘Bath Salts’ Products , 2013, Neuropsychopharmacology.
[62] A. Moszczynska,et al. Amphetamine toxicities , 2010, Annals of the New York Academy of Sciences.
[63] Kurt R. Lehner,et al. Psychoactive "bath salts": not so soothing. , 2013, European journal of pharmacology.
[64] F. Ebling,et al. Contribution of serotonin and dopamine to changes in core body temperature and locomotor activity in rats following repeated administration of mephedrone , 2016, Addiction biology.
[65] K. Rice,et al. In vivo Effects of Abused ‘Bath Salt’ Constituent 3,4-methylenedioxypyrovalerone (MDPV) in Mice: Drug Discrimination, Thermoregulation, and Locomotor Activity , 2013, Neuropsychopharmacology.
[66] A. Janowsky,et al. Substituted methcathinones differ in transporter and receptor interactions. , 2013, Biochemical pharmacology.
[67] K. Esser,et al. Voluntary exercise protects against methamphetamine-induced oxidative stress in brain microvasculature and disruption of the blood–brain barrier , 2009, Molecular Neurodegeneration.
[68] G. Ricaurte,et al. Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuse. , 1996, The Journal of pharmacology and experimental therapeutics.
[69] E. Mervaala,et al. Keto amphetamine toxicity-focus on the redox reactivity of the cathinone designer drug mephedrone. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.
[70] M. Colado,et al. Current preclinical studies on neuroinflammation and changes in blood–brain barrier integrity by MDMA and methamphetamine , 2014, Neuropharmacology.
[71] F. Nagai,et al. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. , 2007, European journal of pharmacology.
[72] N. Murakami,et al. Cardiovascular, thermal and behavioral sensitization to methamphetamine in freely moving rats. , 1993, The Journal of pharmacology and experimental therapeutics.
[73] J. Camarasa,et al. Serotonergic impairment and memory deficits in adolescent rats after binge exposure of methylone , 2014, Journal of psychopharmacology.
[74] D. Kuhn,et al. The newly synthesized pool of dopamine determines the severity of methamphetamine‐induced neurotoxicity , 2008, Journal of neurochemistry.
[75] R. Moratalla,et al. Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms , 2017, Progress in Neurobiology.
[76] A. Green,et al. Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone‐induced hypothermia , 2013, British journal of pharmacology.
[77] R. Glennon,et al. Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para‐substituted methcathinone analogues , 2015, British journal of pharmacology.
[78] P. Couraud,et al. Carrier-Mediated Cocaine Transport at the Blood-Brain Barrier as a Putative Mechanism in Addiction Liability , 2014, The international journal of neuropsychopharmacology.
[79] Andreas Meisel,et al. Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview , 2009, Molecular Neurobiology.
[80] K. Houseknecht,et al. Mephedrone (4‐methylmethcathinone) supports intravenous self‐administration in Sprague‐Dawley and Wistar rats , 2013, Addiction biology.
[81] K. Foley,et al. Methcathinone is a substrate for the serotonin uptake transporter. , 2003, Pharmacology & toxicology.
[82] Ana Margarida Araújo,et al. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of ‘legal high’ packages containing synthetic cathinones , 2014, Archives of Toxicology.
[83] A. Riley,et al. Age-dependent MDPV-induced taste aversions and thermoregulation in adolescent and adult rats. , 2014, Developmental psychobiology.
[84] C. Lay,et al. Effects of (±)3,4-methylenedioxymethamphetamine, (±)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques , 2006, Neuroscience.
[85] D. Sulzer,et al. Amphetamine and Other Weak Bases Act to Promote Reverse Transport of Dopamine in Ventral Midbrain Neurons , 1993, Journal of neurochemistry.
[86] T. Dickerson,et al. In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats , 2015, Psychopharmacology.
[87] D. Kuhn,et al. Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines , 2004, Neuroscience Letters.
[88] R. Glennon,et al. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter , 2013, British journal of pharmacology.
[89] G. Hanson,et al. 4-Methylmethcathinone (Mephedrone): Neuropharmacological Effects of a Designer Stimulant of Abuse , 2011, Journal of Pharmacology and Experimental Therapeutics.
[90] M. Gygi,et al. Methcathinone: an initial study of its effects on monoaminergic systems. , 1996, The Journal of pharmacology and experimental therapeutics.
[91] M Coppola,et al. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food". , 2012, Toxicology letters.
[92] Michael H. Baumann,et al. 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings , 2006, Psychopharmacology.
[93] C. Fontes-Ribeiro,et al. The TNF-α/Nf-κB Signaling Pathway has a Key Role in Methamphetamine–Induced Blood–Brain Barrier Dysfunction , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[94] M. Kane,et al. Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA , 2013, Journal of neurochemistry.
[95] B. Blough,et al. Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV) , 2014, Neuropharmacology.
[96] J. Kelly,et al. Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. , 2011, Drug testing and analysis.
[97] I. McGregor,et al. Mephedrone (4‐methylmethcathinone, ‘meow’): acute behavioural effects and distribution of Fos expression in adolescent rats , 2012, Addiction biology.